New score for the determination of myocardial compromise in patients recovered from covid 19

The cardiovascular compromise due to SARS-CoV-2 has been identified as a poor prognostic variable in this group of patients. A decrease in global left ventricle strain and at the basal segments was recently observed in patients hospitalized for SARS-CoV-2. A very important number of patients remain with dyspnea beyond the first 14 days. Objective: To identify the correlation between a new strain score (IBMA) and the persistence of dyspnea at the time of evaluation in patients recovered from COVID-19. Method: There were 105 patients analyzed;59 were asymptomatic (group 1) and 46 had dyspnea (group 2). The GLS of the left ventricle and the average of the basal and mid-apical segments were determined. The basal/medial-apical index (IBMA) was determined. Results: There were no significant differences in the standard echocardiographic variables (ventricular volumes, ejection fraction, etc.). There was a non-significant decrease in the longitudinal strain values of the basal segments. A difference of IBMA greater than 15% was observed in 74% of the patients in group 2, and none of the patients in the control group (p 0.0002). Conclusion: Through the proposal of a new correlation index (IBAM), we have identified an abnormal pattern of global longitudinal strain of the basal segments related with the middle and apical segments. This was present in the group with persistent dyspnea after the first stage of the SARS CoV-2 disease.